Tumor-repopulating cell-derived microparticles elicit cascade amplification of chemotherapy-induced antitumor immunity to boost anti-PD-1 therapy

Immune checkpoint blockade (ICB) therapy, particularly antibodies targeting the programmed death receptor 1 (PD-1) and its ligand (PD-L1), has revolutionized cancer treatment. However, its efficacy as a standalone therapy remains limited. Although ICB therapy in combination with chemotherapy shows p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bie, Nana, Yong, Tuying, Wei, Zhaohan, Liang, Qingle, Zhang, Xiaoqiong, Li, Shiyu, Li, Xin, Li, Jianye, Gan, Lu, Yang, Xiangliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598206/
https://www.ncbi.nlm.nih.gov/pubmed/37875473
http://dx.doi.org/10.1038/s41392-023-01658-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598206/
https://www.ncbi.nlm.nih.gov/pubmed/37875473
http://dx.doi.org/10.1038/s41392-023-01658-3

Ejemplares similares